Second Annual Primary Care NAFLD/NASH Summit

---

Primary Care NAFLD/NASH Summit Opening

Michael Betel, FLA & 

Marko Korenjak, ELPA

  Overview of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 

Aleksander Krag 

Prevalence and risk factors for NAFLD and NASH

Professor Jeff Lazarus 

Pathophysiology of NAFLD and NASH  Professor Naim Alkhouri 

• Definition of NAFLD and NASH

• Stages of NAFLD and NASH

• Understanding the progression of NAFLD to NASH and its associated complications 

Clinical presentation and diagnostic criteria of NAFLD and NASH  

Professor Giada Sebastiani 

 Importance of screening for NAFLD and NASH in high-risk populations

Professor Mazen Noureddin   

Panel Discussion

Q and A

Dr. James Kim, Professor Mazen Noureddin, Professor Aleksander Krag and Professor Giada Sebastiani

 The New Nomenclature for NAFLD and NASH – why the change? What does this mean for clinicians and patients? 

Professor Maru Rinella 

  Management of NAFLD and NASH

• Lifestyle modifications as the primary treatment approach, include accessibility challenges Professor Manal Abdelmalek 

• Pharmacological treatments for NAFLD and NASH – Stephen Harrison

• Monitoring disease progression and response to treatment  

 Case study and Panel Discussion 

• Applications in the real world: case study

• Panel discussion:

Manal Abdelmalek, Maru Rinella, Mia Biondi, and Stephen Harrison

  Referral and Collaboration

• Indications for referral to a specialist – Panel: Professor Mark Swain and Dr. Hsiao-Ming Jung and Professor Ken Cusi with Michael Betel facilitating 

• Importance of interdisciplinary collaboration for optimal patient care: Panel